Cancer Genetics Q4 Revenues Improve 73 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that its fourth quarter revenues increased 73 percent year over year.

For the three months ended Dec. 31, 2013 the Rutherford, NJ-based cancer diagnostics firm reported revenues of $1.9 million, up from $1.1 million in the year-ago quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."